Stockholm, May 22, 2012 – Karo Bio AB’s annual report for 2011 is as of today available on the company’s website www.karobio.com.
The printed version of the annual report will be distributed to shareholders and others specifically subscribing to the printed version. It can also be ordered from Karo Bio by mail to Karo Bio AB, attn: Eva Kruse, Novum, 141 57 Huddinge, Sweden, by fax to +46 8 774 8261, or by e-mail to  .

 
For further information please contact:

Per Bengtsson, CEO
Phone: +46 76 002 6020

 

About Karo Bio

Karo Bio is a research and development company focused on innovative drugs for large medical needs. The foundation for operations is a unique knowledge of nuclear receptors as target proteins for the development of novel pharmaceuticals and the related mechanisms of action, as well as experience and expertise in preclinical and clinical development.

Karo Bio is active in preclinical development in the areas of neuropsychiatry, inflammation,...